Oncolytics Biotech, Inc. (ONCY)
0.9921
+0.01
(+1.16%)
USD |
NASDAQ |
Dec 05, 16:00
0.97
-0.02
(-2.23%)
After-Hours: 07:56
Oncolytics Biotech Research and Development Expense (TTM): 13.59M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 29.72M |
| Edesa Biotech, Inc. | 2.547M |
| Lexaria Bioscience Corp. | 8.239M |
| Xenon Pharmaceuticals, Inc. | 270.15M |
| ProMIS Neurosciences, Inc. | 28.34M |